Default company panoramic image

CellBank Technologies LLC

CellBank provides joint replacement patients the choice to preserve valuable bone graft and stem cells for use in future medical procedures.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Cleveland, OH, USA
  • Currency USD
  • Founded July 2011
  • Employees 4
  • Website

Company Summary

CellBank will collect normally discarded bone, marrow and stem cells from the 1 million people who have knee/hip replacement surgeries each year. CellBank will process, store and deliver this stem cell-rich tissue for their bone grafting surgeries and future approved stem cell therapies. The CellBank method of capturing tissue yields sufficient volume without requiring an additional procedure AND affords multiple uses from a single collection.


  • Default avatar
    Aaron M Caplan
    Chief Executive Officer

    A successful leader with 20+ yrs at large companies such as Andersen Consulting and Home Depot and start-ups and Critical Solutions. With a focus in operations, process design/improvement and customer service, he consistently drives business performance across industries including 200% revenue growth (Critical Solutions) and 11% expense reduction (Home Depot). Mr. Caplan has an MBA from the Weatherhead School of Management, CWRU.

  • Default avatar
    Rachel C Uram

    She has extensive experience in strategic marketing, product development, and operations/project mgmt. Uram has launched new products/lines of business for large (Quaker Oats), start-up (ShopLocal), and public (Chicago Transit Authority) entities. Ms. Uram (BSE from Wharton; MBA in Finance/Mktg from Univ of Chicago) combines analytic thinking, deep cross-functional and marketing expertise, creativity, and efficient execution to deliver results.

  • Default avatar
    Arnold I Caplan
    Chief Scientific Officer

    He is a global leading expert in stem cell technology and recognized as #6 of the Top 50 Stem Cell Influencers. He has 40+ yrs in regenerative medicine and orthopedics, 400+ papers, 21 patents and 6 provisionals. A much sought-after industry consultant, he also founded businesses including Osiris and Cell Targeting (acquired by BioTime). Dr. Caplan is Professor of Biology and Dir of the Skeletal Res Center at CWRU with a PhD from Johns Hopkins.

  • Default avatar
    Steven Hirsch
    Vice President of Sales

    He brings over 30 years of leadership experience in the orthopedic industry including senior sales and leadership roles at Howmedica and Smith and Nephew where he managed the $700 MM global total joint business unit. Most recently, Mr. Hirsch was also the COO of BioMimetic Therapeutics, an orthobiologic start-up company. He holds a B.E.S from The Johns Hopkins University and an MSIA from the Krannert School of Business, Purdue University.


  • Default avatar
    Benesch, Friedlander, Coplan & Aronoff LLP (general advisory); Porzio, Bromberg & Newman P.C. (general advisory); and Pepper Hamilton LLP (Patent work)
    Default avatar
    SS&G Inc.

Previous Investors

  • Default avatar
    CellBank Founding team investment
    Default avatar
    Angel investment
    Default avatar
    Innovation grant, GLIDE, from Lorain Community College